TGFB1 and cancer: Through the secretion of immune mediators (e.g., TGF-β diminishing natural killer (NK) cell anti-tumor activity) and cell-cell interaction (e.g., platelets coating around cancer cells), platelets contribute to immune suppression and support cancer cell evasion of immune surveillance (Braun et al., 2021).